Polycystic ovary syndrome

Last updated: October 07, 2023

Polycystic ovary syndrome

6400

6400

Anatomy of the pelvic girdle
Anatomy of the pelvic cavity
Anatomy of the male reproductive organs of the pelvis
Anatomy of the perineum
Anatomy clinical correlates: Male pelvis and perineum
Anatomy of the female urogenital triangle
Anatomy clinical correlates: Female pelvis and perineum
Development of the reproductive system
Prostate gland histology
Testis, ductus deferens, and seminal vesicle histology
Penis histology
Anatomy and physiology of the male reproductive system
Testosterone
Hypospadias and epispadias
Priapism
Prostatitis
Penile cancer
Cryptorchidism
Varicocele
Orchitis
Testicular cancer
Epididymitis
Testicular torsion
Hernias: Clinical
Vaginal and vulvar disorders: Pathology review
Cervical cancer: Pathology review
Cervical cancer
Menstrual cycle
Anatomy and physiology of the female reproductive system
Prostate cancer
Benign prostatic hyperplasia
Inguinal hernia
Ovarian cyst
Premature ovarian failure
Polycystic ovary syndrome
Ovarian torsion
Ovarian sex-cord stromal tumors
Ovarian germ cell tumors
Ovarian surface epithelial tumors
Endometritis
Endometrial cancer
Endometriosis
Endometrial hyperplasia
Choriocarcinoma
Uterine fibroid
Testicular tumors: Pathology review
Uterine disorders: Pathology review
Ovarian cysts and tumors: Pathology review
Amenorrhea
Amenorrhea: Clinical
Amenorrhea: Pathology review
Ectopic pregnancy
Virilization: Clinical
Abnormal uterine bleeding: Clinical
Haemophilus ducreyi (Chancroid)
Treponema pallidum (Syphilis)
Herpes simplex virus
Chlamydia trachomatis
Gardnerella vaginalis (Bacterial vaginosis)
Neisseria gonorrhoeae
Candida
Trichomonas vaginalis
Arteries and veins of the pelvis
Nerves and lymphatics of the pelvis
Anatomy of the inguinal region
Anatomy of the male urogenital triangle
Anatomy of the breast
Anatomy clinical correlates: Breast
Mammary gland histology
Ovary histology
Fallopian tube and uterus histology
Cervix and vagina histology
Puberty and Tanner staging
Estrogen and progesterone
Menopause
Pregnancy
Oxytocin and prolactin
Stages of labor
Breastfeeding
Erectile dysfunction
Male hypoactive sexual desire disorder
Female sexual interest and arousal disorder
Pelvic inflammatory disease
Urethritis
Androgens and antiandrogens
Adrenergic antagonists: Alpha blockers
PDE5 inhibitors
Estrogens and antiestrogens
Progestins and antiprogestins
Aromatase inhibitors
Sexually transmitted infections: Clinical
Human development days 1-4
Human development days 4-7
Human development week 2
Human development week 3
Infertility: Clinical
Placenta previa
Development of the placenta
Turner syndrome
Klinefelter syndrome
Fragile X syndrome
Ovarian cysts, cancer, and other adnexal masses: Clinical
Galactosemia
Hyperemesis gravidarum
Complications during pregnancy: Pathology review
Vulvovaginitis: Clinical
Endometrial hyperplasia and cancer: Clinical
Cervical cancer: Clinical
Vaginal cancer: Clinical
Vulvar cancer: Clinical
Fetal circulation
Preeclampsia & eclampsia
Hypertensive disorders of pregnancy: Clinical
Uterine stimulants and relaxants
cGMP mediated smooth muscle vasodilators
Postpartum hemorrhage: Clinical
Placenta accreta
Placental abruption
Antepartum hemorrhage: Clinical
Abnormal labor: Clinical
Gestational trophoblastic disease: Clinical
Krukenberg tumor
Breast cancer: Pathology review
Benign breast conditions: Pathology review
Breast cancer
Fibrocystic breast changes
Breast cancer: Clinical
Anatomy of the female reproductive organs of the pelvis
Precocious puberty
Delayed puberty
Androgen insensitivity syndrome
5-alpha-reductase deficiency
Kallmann syndrome
Bladder exstrophy
Orgasmic dysfunction
Genito-pelvic pain and penetration disorder
Mastitis
Intraductal papilloma
Phyllodes tumor
Paget disease of the breast
Gestational hypertension
Gestational diabetes
Cervical incompetence
Oligohydramnios
Polyhydramnios
Potter sequence
Intrauterine growth restriction
Preterm labor
Postpartum hemorrhage
Chorioamnionitis
Congenital toxoplasmosis
Congenital cytomegalovirus (NORD)
Congenital syphilis
Neonatal conjunctivitis
Neonatal herpes simplex
Congenital rubella syndrome
Neonatal sepsis
Neonatal meningitis
Miscarriage
Gestational trophoblastic disease
Fetal hydantoin syndrome
Fetal alcohol syndrome
Disorders of sex chromosomes: Pathology review
Prostate disorders and cancer: Pathology review
Congenital TORCH infections: Pathology review
Disorders of sexual development and sex hormones: Pathology review
Testicular and scrotal conditions: Pathology review

Transcript

Watch video only

In polycystic ovary syndrome, “poly” means many, and “cystic” refers to cysts.

So you might think that having many ovarian cysts is a crucial part of polycystic ovary syndrome.

But while some people with polycystic ovarian syndrome do have ovarian cysts, ovarian cysts are no longer a necessary characteristic of the condition.

Instead, polycystic ovary syndrome is a dysfunction in the hypothalamic-pituitary-ovarian axis, which are the hormones that regulate the menstrual cycle.

A normal menstrual cycle can be divided into two phases: the follicular phase, which takes place before ovulation, and the luteal phase, which takes place after ovulation.

During the follicular phase, the hypothalamus secretes gonadotropin-releasing hormone, or GnRH.

GnRH makes the anterior pituitary gland secrete two other hormones, called gonadotropins, in roughly equal amounts, which it releases in pulses.

One of these gonadotropins is the luteinizing hormone, or LH.

The other is the follicle-stimulating hormone, or FSH.

LH and FSH travel to the follicles in the ovaries.

The follicles are small clusters of theca and granulosa cells that protect the developing oocyte, or egg.

The theca cells develop LH receptors which allow them to bind LH, and in response they secrete a hormone called androstenedione.

Granulosa cells develop FSH receptors, which allow them to bind to FSH and produce an enzyme called aromatase, which converts the androstenedione into 17β-estradiol - a member of the estrogen family.

As follicles grow, the level of 17β-estradiol in the blood increases, and it acts as a negative feedback signal – that is, it tells the pituitary to secrete less FSH.

Less FSH in the blood means there’s only enough to stimulate one follicle.

The follicle that has the most FSH receptors grows the quickest, and becomes the dominant follicle.

At this point, about midway through the follicular phase, the granulosa cells also begin to develop LH receptors.

As that happens, the dominant follicle keeps secreting estrogen, and the rising estrogen levels make the pituitary more sensitive to the pulsatile action of GnRH from the hypothalamus.

Blood estrogen levels start to climb, and now the estrogen from the dominant follicle becomes a positive feedback signal – that is, it makes the pituitary secrete a whole lot of FSH and LH in response to GnRH.

This happens a day or two before ovulation, and the massive surge of FSH and LH binds to the granulosa and theca cells which help facilitate rupture of the ovarian follicle and release of the oocyte.

While the rest theca and granulosa cells degenerate and die off, a now fully-matured oocyte breaks away from the dominant follicle, and pops out of the ovary.

The egg begins its journey down the fallopian tube to the uterus. The luteal phase has begun.

While polycystic ovary syndrome affects the whole menstrual cycle, it really starts with a breakdown in this follicular phase.

In polycystic ovarian syndrome, the anterior pituitary makes too much LH, at least double the amount as FSH.

Excessive LH causes the theca cells to produce excess amounts of androstenedione, way too much for those granulosa cells to convert.

Key Takeaways

Polycystic ovary syndrome or just PCOS, refers to a set of symptoms due to excessive androgen production in women. Signs and symptoms of PCOS include irregular or no menstrual periods, heavy periods, excess body and facial hair, acne, pelvic pain, trouble getting pregnant, and patches of thick, darker, velvety skin. Associated conditions include type 2 diabetes, obesity, obstructive sleep apnea, heart disease, mood disorders, and endometrial cancer. Management for PCOS may involve lifestyle modifications such as diet and exercise, hormone therapy, and medications.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 7/E (ENHANCED EBOOK)" McGraw Hill Professional (2014)
  4. "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
  5. "Harrison's Endocrinology, 4E" McGraw-Hill Education / Medical (2016)
  6. "Genetic, hormonal and metabolic aspects of PCOS: an update" Reproductive Biology and Endocrinology (2016)
  7. "Androgens in Polycystic Ovary Syndrome: The Role of Exercise and Diet" Seminars in Reproductive Medicine (2009)